Rebeca Ramos-Zayas

This inventor holds 17 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Crispr Therapeutics Ag. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rebeca Ramos-Zayas. Retrieved from https://idiyas.com/inventor/rebeca-ramos-zayas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 2.0

ph-index = 6

Forward Citations = 74(Granted Patents)

Company Filing History:

17 out of 86

Crispr Therapeutics Ag

patents

Years Active: 2020-2026

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12584144 - UNIVERSAL DONOR CELLS (2026-03-24),

2. 12577582 - UNIVERSAL DONOR CELLS (2026-03-17),

3. 12427170 - Universal donor cells (2025-09-30),

4. 12378572 - Universal donor cells (2025-08-05),

5. 12365915 - Universal donor cells (2025-07-22),

6. 11434505 - Universal donor cells (2022-09-06),

7. 11433103 - Universal donor cells (2022-09-06),

8. 11180776 - Universal donor cells (2021-11-23),

9. 11118196 - Universal donor cells (2021-09-14),

10. 11118195 - Universal donor cells (2021-09-14),

11. 11116798 - Universal donor cells (2021-09-14),

12. 11116797 - Universal donor cells (2021-09-14),

13. 11104918 - Universal donor cells (2021-08-31),

14. 11008587 - Universal donor cells (2021-05-18),

15. 11008586 - Universal donor cells (2021-05-18),

Title: Rebeca Ramos-Zayas: Innovator in Genetic Engineering

Introduction

Rebeca Ramos-Zayas is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of genetic engineering, particularly in the development of universal donor cells. With a total of 15 patents to her name, her work is paving the way for advancements in medical science.

Latest Patents

One of her latest patents focuses on universal donor cells, which are genetically modified cells designed to be compatible with multiple subjects. The patent details methods for generating these genetically modified cells, which include at least one genetic modification within or near a gene that encodes a survival factor. This innovation aims to enhance the compatibility of donor cells, making them more effective for various medical applications. The universal donor cells may also include modifications related to human leukocyte antigens, further increasing their utility in transplantation and therapy.

Career Highlights

Rebeca is currently associated with Crispr Therapeutics AG, where she continues to push the boundaries of genetic research. Her work has garnered attention for its potential to revolutionize how we approach organ transplantation and immune response management.

Collaborations

Some of her notable coworkers include Alireza Rezania and Tony W. Ho, who collaborate with her on various projects aimed at advancing genetic engineering technologies.

Conclusion

Rebeca Ramos-Zayas is a trailblazer in the field of genetic engineering, with her innovative work on universal donor cells showcasing her commitment to improving medical science. Her contributions are expected to have a lasting impact on the future of healthcare.

Profile summary based on public USPTO records.